DDGP versus SMILE in NK/T-Cell Lymphoma-Letter.
作者： Vineet Govinda Gupta , Ajay Gogia
DOI: 10.1158/1078-0432.CCR-16-1076
关键词:
摘要: We read with interest the randomized controlled trial by Li and colleagues ([1][1]) comparing DDGP (dexamethasone, cisplatin, gemcitabine, pegasparaginase) to SMILE methotrexate, ifosfamide, l-asparaginase, etoposide) in patients stage III–IV NK/T-cell lymphoma (NKTCL). While
aacrjournals.org
sci-hub.se 参考文章(4)
Yok-Lam Kwong, Won Seog Kim, Soon Thye Lim, Seok Jin Kim, Tiffany Tang, Eric Tse, Anskar Y. H. Leung, Chor-Sang Chim, SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group Blood. ,vol. 120, pp. 2973- 2980 ,(2012) , 10.1182/BLOOD-2012-05-431460
Motoko Yamaguchi, Yok-Lam Kwong, Won Seog Kim, Yoshinobu Maeda, Chizuko Hashimoto, Cheolwon Suh, Koji Izutsu, Fumihiro Ishida, Yasushi Isobe, Eisaburo Sueoka, Junji Suzumiya, Takao Kodama, Hiroshi Kimura, Rie Hyo, Shigeo Nakamura, Kazuo Oshimi, Ritsuro Suzuki, Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study Journal of Clinical Oncology. ,vol. 29, pp. 4410- 4416 ,(2011) , 10.1200/JCO.2011.35.6287
Kevin Tay, Miriam Tao, Richard Quek, Soon Thye Lim, Alexandre Chan, Tiffany Tang, Terence Ng, Vivianne Shih, To SMILE or Not: Supportive Care Matters Journal of Clinical Oncology. ,vol. 30, pp. 1015- 1016 ,(2012) , 10.1200/JCO.2011.40.7098
Xin Li, Yingying Cui, Zhenchang Sun, Lei Zhang, Ling Li, Xinhua Wang, Jingjing Wu, Xiaorui Fu, Wang Ma, Xudong Zhang, Yu Chang, Feifei Nan, Wencai Li, Liping Su, Jinghua Wang, Hongwei Xue, Mingzhi Zhang, DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China Clinical Cancer Research. ,vol. 22, pp. 5223- 5228 ,(2016) , 10.1158/1078-0432.CCR-16-0153